FibroGen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. 

CEO
Thane Wettig
CEOThane Wettig
Employees
225
Employees225
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1993
Founded1993
Employees
225
Employees225

FGEN Key Statistics

Market cap
31.28M
Market cap31.28M
Price-Earnings ratio
-3.18
Price-Earnings ratio-3.18
Dividend yield
Dividend yield
Average volume
60.69K
Average volume60.69K
High today
$8.36
High today$8.36
Low today
$7.65
Low today$7.65
Open price
$8.16
Open price$8.16
Volume
15.06K
Volume15.06K
52 Week high
$38.25
52 Week high$38.25
52 Week low
$4.50
52 Week low$4.50

FGEN News

TipRanks 4d
FibroGen Amends Financing Agreement with Morgan Stanley

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own FGEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.